Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus Exelon Corporation EXC Evolving Regulatory Capital Expenditure and Valuation Narratives Signal Mixed NearTerm Headwinds and LongTerm Upside RMSGW Real CEO shares optimistic strategic growth roadmap following release of its latest quarterly earnings